LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 3756 | 3895 | 0.9641 | 0.9907 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 1804 | 3895 | 0.4631 | 0.8125 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 3536 | 3895 | 0.9077 | 0.9754 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 2 | 3895 | 0.0005 | -0.2409 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 4805 | 3895 | 1.2334 | 1.0544 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 7 | 3895 | 0.0018 | -0.1090 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 44.42 | 17.25 | 4612 | 3895 | 1.1839 | 1.0436 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 3338 | 4141 | 0.8060 | 0.9462 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 4103 | 4141 | 0.9907 | 0.9976 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 2241 | 4141 | 0.5411 | 0.8505 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 3895 | 4141 | 0.9405 | 0.9845 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 5 | 4141 | 0.0012 | -0.1450 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 5270 | 4141 | 1.2725 | 1.0619 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 2 | 4141 | 0.0005 | -0.2385 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.39 | 17.25 | 5087 | 4141 | 1.2283 | 1.0527 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 3533 | 4390 | 0.8047 | 0.9464 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 4441 | 4390 | 1.0115 | 1.0029 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 2313 | 4390 | 0.5268 | 0.8459 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 4216 | 4390 | 0.9603 | 0.9899 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 7 | 4390 | 0.0016 | -0.1067 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 5702 | 4390 | 1.2988 | 1.0665 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 2 | 4390 | 0.0005 | -0.2363 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.36 | 17.25 | 5466 | 4390 | 1.2450 | 1.0556 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.33 | 17.25 | 3827 | 4651 | 0.8228 | 0.9523 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.33 | 17.25 | 4831 | 4651 | 1.0387 | 1.0094 | MN20160310_N02 | D03 |